Senior Vendor Laboratory Manager Clinical Laboratory & Biospecimen Management

Bio Marin is a leading rare disease biotechnology company focused on genetically defined conditions.

Guided by our purpose to develop medicines that make a profound impact on people's lives, our global teams have delivered a portfolio of therapies since our founding in 1997. Our revolutionary treatments for conditions like achondroplasia (the most common form of dwarfism), PKU (phenylketonuria), CLN2, a form of Batten disease, and a number of forms of MPS (mucopolysaccharidosis) offer new possibilities for patients and families who previously had few, if any, available options.

More recently, with the close of the Amicus acquisition, our portfolio has expanded to include therapies for Fabry disease and Pompe disease, expanding our ability to reach more people living with rare genetic conditions.

Our success comes from our unwavering commitment to excellence, our deep understanding of patient needs, our scientific expertise, and our world-class manufacturing capabilities. At the heart of Bio Marin is a dedicated team of the brightest minds in the industry working together to deliver innovative therapies to patients and families around the world.

From research and discovery to post-market clinical development, our R&D engine involves all bench and clinical research and the associated groups that support those endeavors. Our teams work on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients who live with rare diseases.

Clinical Laboratory & Biospecimen Management (CLBM) is a high-impact partner within the Global Development Organization (GDO), enabling Bio Marin's clinical development success through industry-leading vendor oversight and ethical biospecimen management. CLBM implements standardized best practices to ensure the delivery of reliable, high-quality data that supports confident, data-driven decision-making in rare disease development and reduces operational and compliance risk across the clinical development portfolio.

In addition to vendor oversight, CLBM is responsible for the governance and long‑term stewardship of clinical trial biospecimens, including biorepository management to support ongoing and future research initiatives.

The Senior Vendor Laboratory Manager (SVLM) is a senior operational leader within CLBM responsible for program-level laboratory and biospecimen management oversight. In addition to independently performing the responsibilities of the Vendor Laboratory Manager, the SVLM serves as a functional subject matter expert, strategic partner, mentor, and matrix leader. The SVLM leads complex programs, resolves high‑impact vendor and operational issues, strengthens CLBM tools and operating practices, and influences cross‑functional decision‑making to ensure compliant, efficient, and high‑quality delivery across the clinical development portfolio.

• Lead CLBM delivery across complex studies, multiple studies, or selected programs, ensuring laboratory and biospecimen activities remain aligned with protocol requirements, timelines, intended use, and decision‑making needs.
• Provide senior‑level oversight of study start‑up, maintenance, close‑out, and vendor transition activities to ensure clinical timelines and deliverables are met.
• Identify cross‑study dependencies, risks, and process gaps and drive resolution through structured action plans and stakeholder alignment.
• Review senior leadership top‑line updates and ensure CLBM deliverables, risks, and milestones are accurate, current, and appropriately represented.

• Serve as CLBM lead or senior advisor for complex vendor relationships, high‑risk operational issues, and escalations requiring advanced judgment.
• Contribute to vendor sourcing, selection, scope development, contract modeling, pricing assumptions, and performance oversight for central and specialty laboratories.
• Evaluate vendor capabilities, operational models, emerging technologies, and assay feasibility to inform future program needs and…